Thalidomide-associated deep vein thrombosis and pulmonary embolism - 02/09/11
Doi : 10.1016/S0002-9343(02)01300-1
Charles L Bennett, MD, PhD a, b, ⁎ 
, Glen T Schumock, PharmD, MBA c, Apurva A Desai, MD d, Hau C Kwaan, MD, PhD a, b, Dennis W Raisch, PhD e, Rebecca Newlin a, Walter Stadler, MD d
, Glen T Schumock, PharmD, MBA c, Apurva A Desai, MD d, Hau C Kwaan, MD, PhD a, b, Dennis W Raisch, PhD e, Rebecca Newlin a, Walter Stadler, MD d a MidWest Center for Health Services and Policy Research and the Chicago VA Healthcare System/Lakeside Division (CLB, RN, HCK), Chicago, Illinois, USA
b Division of Hematology/Oncology and the Robert H. Lurie Comprehensive Cancer Center (CLB, HCK), Northwestern University, Chicago, Illinois, USA
c Department of Pharmacy Practice (GTS), University of Illinois at Chicago College of Pharmacy, Chicago, Illinois, USA
d Division of Hematology/Oncology and the University of Chicago Comprehensive Cancer Center of the University of Chicago School of Medicine (AAD, WS), Chicago, Illinois, USA
e VA Cooperative Studies Program Clinical Research Pharmacy Coordinating Center (DWR), University of New Mexico, Albuquerque, New Mexico, USA
*Requests for reprints should be addressed to Charles L. Bennett, MD, PhD, Health Services Research, Chicago VA Medical Center, Lakeside Division, 400 East Ontario, Room 205, Chicago, Illinois 60611, USA
Vol 113 - N° 7
P. 603-606 - novembre 2002 Retour au numéro
Article précédent
- Transient proarrhythmic state following atrioventricular junction radiofrequency ablation: pathophysiologic mechanisms and recommendations for management
- Karolina Nowinski, Fredrik Gadler, Mats Jensen-Urstad, Lennart Bergfeldt
- Cases from the Osler Medical Service at Johns Hopkins University
- Jacob M. Mishell
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?